DVA

#789
DaVita Inc. Common Stock
196.0 0 USD
-0.58%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
196.00
197.06
Range Annuel
101.00
202.58
Changement quotidien
-0.58%
Changement Mensuel
+29.87%
Evolution sur 6 mois
+64.33%
Changement Annuel
+44.56%
Clôture Précédente
197.1 4
Open
197.0 6
Low
196.0 0
High
197.0 6
Volume
33
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
  • Market Capitalization 12.58 B
  • Employee 78 K
  • Founded 1992
  • CEO Javier J. Rodriguez
  • Website www.davita.com
  • Headquarter Delaware, United States
  • FIGI BBG000MQ1SN9
  • Industry Établissements de Soins Médicaux
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
11.55
ratio cours/chiffre d'affaires
0.63

DaVita Inc. Common Stock

DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500.

Nouvelles